Skip to main content
رجوع
SSII logo

SS Innovations International, Inc.

جودة البيانات: 100%
SSII
NASDAQ Healthcare Medical - Devices
KWD 4.86
▲ KWD 0.03 (0.62%)
القيمة السوقية: 944.58M
نطاق اليوم
KWD 4.82 KWD 4.95
نطاق 52 أسبوعًا
KWD 3.02 KWD 22.42
حجم التداول
26,545
متوسط 50 يوم / 200 يوم
KWD 4.71 / KWD 6.01
الإغلاق السابق
KWD 4.83

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -77.9 0.2
P/B 24.7 3.0
ROE % -46.9 3.6
Net Margin % -28.6 3.8
Rev Growth 5Y % 9.9
D/E 0.1 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

لا تتوفر تقديرات مستقبلية

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-10 N/A -KWD 0.01
2025-10-28 N/A -KWD 0.02
2025-08-07 N/A KWD 0.00
2025-05-14 N/A -KWD 0.03
2025-03-27 N/A -KWD 0.04
2024-11-15 N/A -KWD 0.03
2024-09-06 N/A -KWD 0.02
2024-05-15 N/A -KWD 0.02

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Debt/Equity of 0.08 — conservative balance sheet
Negative free cash flow of -22.20M
Capital efficient — spends only 8.63% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)105.40%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-46.94%
ROIC-14.86%
Net Margin-28.59%
Op. Margin-19.22%

الأمان

Debt / Equity
0.08
Current Ratio1.86
Interest Coverage-7.35

التقييم

P/E Ratio
-77.89
Forward P/EN/A
P/B Ratio24.72
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 105.40% Revenue Growth (3Y) 168.58%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 42.41M Net Income (TTM) -12.13M
ROE -46.94% ROA -16.34%
Gross Margin 43.38% Operating Margin -19.22%
Net Margin -28.59% Free Cash Flow (TTM) -22.20M
ROIC -14.86% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.08 Current Ratio 1.86
Interest Coverage -7.35
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -77.89 Forward P/E N/A
P/B Ratio 24.72 P/S Ratio 22.27
PEG Ratio 2.12 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -2.35%
Market Cap 944.58M Enterprise Value 944.29M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 42.41M 20.65M 5.88M 1.46M 0.0
Net Income -12.13M -19.15M -20.94M -5.60M -1.48M
EPS (Diluted) -0.06 -0.10 -0.16 -1.41 -0.52
Gross Profit 18.40M 8.45M 713,447.0 489,594.0 -18,787.0
Operating Income -8.15M -18.98M -20.67M -5.68M -1.41M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 74.23M 42.39M 25.48M 6.98M 428,607.0
Total Liabilities 36.01M 28.93M 11.18M 9.66M 287,281.0
Shareholders' Equity 38.22M 13.46M 14.30M -2.68M 141,326.0
Total Debt 2.92M 18.20M 8.22M 8.27M 145,000.0
Cash & Equivalents 3.21M 466,500.0 7.03M 217,177.0 405,774.0
Current Assets 48.80M 27.42M 18.38M 4.10M 408,065.0
Current Liabilities 26.24M 21.33M 9.27M 7.77M 287,281.0